Media

STATEMENTS

GemVax to Present Topline Results at Neuro2024 International Symposium

페이지 정보

작성자 관리자 조회127 views 작성일 24-10-22 13:40

본문

We are pleased to announce that the 'Topline Results of the GemVax PSP Clinical Trial' will be presented at the Neuro2024 International Research Symposium in Toronto, Canada. The session is scheduled for October 24, 4:45 PM local time.

 

Neuro2024 is an annual conference that brings together leading experts in neuroscience from around the world to share research on PSP and CBD.

 

The event is hosted by CurePSP, a New York-based non-profit organization founded in 1990, dedicated to supporting patients, families, and experts in the field.




URL: https://give.curepsp.org/event/neuro2024-the-psp-and-cbd-international-research-symposium/e535599


 

댓글목록

등록된 댓글이 없습니다.